Xie J, Huang J, Li X, Sun S, Chen X
Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA, USA.
Curr Med Chem. 2009;16(10):1278-94. doi: 10.2174/092986709787846604.
Progress in nanosynthesis has succeeded in making nanoscale particles from iron oxide under precise quality control. Given the recent great advances in polymer manufacturing, antibody purification, DNA/RNA synthesis and magnetic resonance imaging (MRI), such iron oxide nanoparticles (IONPs) have been enriched with many variables and attracted great interest in studying their potential biomedical applications. After nearly two decades' effort, IONPs have become a powerful platform in many diverse aspects of biomedicine, including MRI, gene and drug delivery, and hyperthermia. While some studies are still at the proof-of-concept stage, others have now been widely used in clinics. With the on-going efforts to enhance their targeting ability and endow more functions, IONPs' future applications are highly expected.
纳米合成技术的进步已成功在精确的质量控制下由氧化铁制备出纳米级颗粒。鉴于近期在聚合物制造、抗体纯化、DNA/RNA合成以及磁共振成像(MRI)方面取得的重大进展,此类氧化铁纳米颗粒(IONPs)具有多种特性,并在研究其潜在生物医学应用方面引起了极大兴趣。经过近二十年的努力,IONPs已成为生物医学诸多不同领域的强大平台,包括MRI、基因和药物递送以及热疗。虽然一些研究仍处于概念验证阶段,但其他一些研究现已广泛应用于临床。随着不断努力提高其靶向能力并赋予更多功能,IONPs的未来应用备受期待。
Curr Med Chem. 2009
Curr Med Chem. 2018-2-12
Curr Cancer Drug Targets. 2011-2
Future Med Chem. 2010-3
Biosensors (Basel). 2023-10-27
Biophys Rev. 2023-10-3
J Funct Biomater. 2022-12-5
Int J Mol Sci. 2022-11-9
J Control Release. 2022-12